Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
425
datasets available to search
ShareScore release 0.9.0
Dataset results
425 results for “Type 1 diabetes mellitus”
Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy
ClinicalTrials.gov study NCT02421510. IPD Sharing: Not stated. Countries: 17. Publications: 5.
Intravenous CTLA4-lg Treatment in Recent Onset Type 1 Diabetes Mellitus
ClinicalTrials.gov study NCT00505375. IPD Sharing: YES. Countries: 2. Publications: 9.
Islet Cell Transplantation Alone and CD34+ Donor Bone Marrow Cell Infusion in Type 1 Diabetes Mellitus
ClinicalTrials.gov study NCT00315614. IPD Sharing: NO. Countries: 1. Publications: 1.
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus on Basal Plus Mealtime Insulin
ClinicalTrials.gov study NCT01658579. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
ClinicalTrials.gov study NCT01683266. IPD Sharing: Not stated. Countries: 13. Publications: 1.
Impact of COVID-19 lockdown on glycemic control in adults with type 1 diabetes mellitus: information and standardized questions regarding follow-up during lockdown
<p>Aim. To examine the impact of the lockdown caused by COVID-19 pandemic on both the glycemic control and the daily habits of a group of patients with type 1 diabetes mellitus (T1DM) using flash continuous glucose monitoring devices (Flash CGM). </p> <p>Methods. Retrospective analysis based on all the information gathered in virtual consultations from a cohort of 50 adult patients with T1DM with follow-up at our site. We compared their CGM metrics during lockdown with their own previous data before the pandemic occurred, as well as the potential psychological and therapeutic changes.</p> <p>Results. We observed a reduction of the average glucose: 160.26 ± 22.55 mg/dl vs. 150 ± 20.96 mg/dl, p=0.0009, estimated HbA1c: 7.21 ± 0.78% vs. 6.83 ± 0.71%, p=000.5, glucose management indicator (GMI) 7.15 ± 0.57 % vs. 6.88 ± 0.49 %, p=0.0003, and glycemic variability (CV): 40.74 ± 6.66 vs. 36.43 ± 6.09 p<0.0001. Time in range showed an improvement: 57.46 ± 11.85% vs a 65.76 ± 12.09%, p<0.0001, without an increase in percentage of time in hypoglycaemia.</p> <p>Conclusions: COVID-19 lockdown was associated with an improvement in glycemic control in patients with T1DM using CGM.</p>
Self-care activities in pediatric patients with type 1 diabetes mellitus
Open the record for dataset details and reuse information.
Peptide Pool Instability of Precancerous Lesion in Rats with Model of Chronic Pancreatitis and/or Without Type 1 Diabetes Mellitus
<p><span><strong>Supplementary table 1. </strong>Data of Shapiro-Wilk (W) normality test and Homogeneity of Variance Test (Levene's F Test).</span></p> <p> </p> <p><span><strong>Supplementary table 2. </strong>Kruskal-Wallis as the overall test (H-values) and posthoc Dunn's test with Bonferroni correction. The corrected α using the Bonferroni correction method is 0.017</span></p>
Markers of Bone Status in Diabetes Mellitus (Type 1 and Type 2)
ClinicalTrials.gov study NCT01870557. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Microvascular Changes in OCT-angiography in Type 1 Diabetes Mellitus at the Onset of the Disease and After Optimization of Glycemic Control.
ClinicalTrials.gov study NCT04888598. IPD Sharing: UNDECIDED. Countries: 1. Publications: 4.
A Study of the Safety and Efficacy of MK-1293 Compared to Lantus™ in Participants With Type 1 Diabetes Mellitus (T1DM) (MK-1293-003)
ClinicalTrials.gov study NCT02059161. IPD Sharing: YES. Countries: 0. Publications: 1.
Investigating the Effectiveness of Tresiba® (Insulin Degludec) After Switching Basal Insulin in a Population With Type 1 or Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT02662114. IPD Sharing: Not stated. Countries: 6. Publications: 2.
Insulin Glulisine and Aspart in Postprandial Glycemic Control After High-GI Meal in Children With Type 1 Diabetes Mellitus
ClinicalTrials.gov study NCT01678235. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Interferon-Alpha for Diabetes Mellitus Type 1
ClinicalTrials.gov study NCT00024518. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Repeated Dosing Study With a New Insulin Glargine Formulation and Lantus® in Patients With Type 1 Diabetes Mellitus
ClinicalTrials.gov study NCT01349855. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Canadian Study of the Effectiveness of Tresiba® (Insulin Degludec) After Switching Basal Insulin in a Population With Type 1 or Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT03674866. IPD Sharing: YES. Countries: 1. Publications: 1.
The Role of Endogenous Glucagon-like Peptide 1 (GLP-1) in Type 2 Diabetes Mellitus (T2DM)
ClinicalTrials.gov study NCT01449019. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Feasibility Study of a Portable Artificial Pancreas System in Type 1 Diabetes Mellitus (T1DM) - Montpellier
ClinicalTrials.gov study NCT01447979. IPD Sharing: Not stated. Countries: 1. Publications: 1.
PK/PD Biosimilarity Study of Gan & Lee Insulin Glargine Injection vs.US & EU Lantus® in Type 1 Diabetes Mellitus Patients
ClinicalTrials.gov study NCT04236895. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Human Islet Transplantation in Brittle Type 1 Diabetes Mellitus. The GRAGIL 2 Study.
ClinicalTrials.gov study NCT00321256. IPD Sharing: Not stated. Countries: 2. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.